Literature DB >> 2275339

Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma.

M Geppert1, C B Ostertag, G Seitz, M Kiessling.   

Abstract

Neuropathological and radiographical findings of two patients with primary CNS B cell lymphoma are presented. Prior to computerized tomographic (CT)-guided stereotactic biopsy both patients had received glucocorticoid therapy which led to marked tumor regression on CT scans and transient improvement of neurological deficits. Despite careful targeting and serial sampling, multiple biopsy specimens examined cytologically, histologically and immunomorphologically showed nonspecific reactive astrogliosis and conspicuous perivascular infiltrates of T lymphocytes. A second biopsy performed after an interval of 2 and 8 weeks, respectively, and short-term discontinuation of dexamethasone therapy in one case, unequivocally established the diagnosis of Non-Hodgkin lymphoma. It is concluded that steroid therapy may obscure the bioptic diagnosis of cerebral lymphoma. In addition to the well-known antiedematous effect of glucocorticoids neuropathologists and neurosurgeons should be aware of a rapid and pronounced lymphodepletive action of steroids on malignant CNS lymphomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275339     DOI: 10.1007/bf00307631

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells.

Authors:  D S Ucker
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

2.  Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.

Authors:  R W Cartun; F B Coles; W T Pastuszak
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

3.  Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts.

Authors:  L Lombardi; E W Newcomb; R Dalla-Favera
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

5.  Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study.

Authors:  Y T So; J H Beckstead; R L Davis
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

6.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

Review 7.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

8.  Primary lymphoma of the central nervous system.

Authors:  L Letendre; P M Banks; D F Reese; R H Miller; P W Scanlon; J M Kiely
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

9.  Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.

Authors:  E A Neuwelt; E P Frenkel; M K Gumerlock; R Braziel; B Dana; S A Hill
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

10.  Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.

Authors:  Y S Yuh; E B Thompson
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

View more
  22 in total

1.  [Diagnosis of an initial infratentorial central nervous system B-cell lymphoma during prolonged cortisone medication].

Authors:  A Buss; A Assmus; J Weidemann; B Sellhaus; J Lorenzen; F Block
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

2.  Atypical manifestation of childhood primary cerebral lymphoma restricted to the leptomeninges.

Authors:  Birgit Uhlenberg; Susanne Reich; Verena Varnholt; Frank K H van Landeghem; Ianina Scheer; Dietrich Berdel; Arend von Stackelberg; Arpad von Moers
Journal:  Eur J Pediatr       Date:  2005-07-26       Impact factor: 3.183

3.  Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature.

Authors:  B Pirotte; M Levivier; S Goldman; J M Brucher; J Brotchi; J Hildebrand
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 4.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

5.  Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma: effect of prior corticosteroid therapy.

Authors:  Elena Kan; Itai Levy; Daniel Benharroch
Journal:  Virchows Arch       Date:  2009-09-09       Impact factor: 4.064

6.  Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

Authors:  Francisco-Javier Peñalver; Juan-Manuel Sancho; Adolfo de la Fuente; María-Teresa Olave; Alejandro Martín; Carlos Panizo; Elena Pérez; Antonio Salar; Alberto Orfao
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

7.  The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.

Authors:  M C Mabray; R F Barajas; J E Villanueva-Meyer; C A Zhang; F E Valles; J L Rubenstein; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

Review 8.  Primary T-cell lymphoma of the cerebellum. A case report.

Authors:  K Kleopa; G Becker; W Roggendorf; H Reichmann
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 9.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

Review 10.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.